Congenica 3.3 improves genomic data analysis and automates workflow
Congenica v3.3 uses Congenica’s AI combined with other platform features to further improve genomic data analysis and automate workflow.
Automating Clinical Genomic Analysis & Reporting for Rapid NGS Results
With the increasing access to exome and genome testing the interpretation of this data is taking longer and longer.
Congenica signs distribution agreement with ATC Healthcare in Turkey
Congenica announces new distribution agreement with ATC Healthcare, a Turkish business investing in advanced tech in molecular diagnosis & life sciences.
Congenica Receives CE Mark for Genomic Analysis Software
Congenica NGS data analysis software for genomic data interpretation is now CE marked under the In Vitro Diagnostics Directive.
Congenica 3.1 - Automating best practices in variant interpretation
Congenica 3.1 release forms part of our ongoing commitment to embedding variant analysis best practices in an automated platform and intuitive workflow.
Achieving the highest diagnostic yield possible with phenotype-based prioritization of variants
Genomic sequencing has the potential to rapidly analyze critically ill babies and children and also to predict a response to infectious diseases and potential therapeutic compounds.
2020 – The Year of Healthcare Heroes and International Teamwork
Nick Lench, PhD, Chief Scientific Officer at Congenica describes a year of heartbreak and uncertainty. But it’s also been a year of heroism, where healthcare workers have fought valiantly to save the ...
Congenica v3.0 - Overcoming Challenges to Accelerate Variant Classification
As more cases undergo genomic testing and the global supply of classified genomic data increases, reducing repetitive work is essential to scaling access to genomic analysis.
How to research COVID-19 host genetics?
Congenica’s COVID-19 host genetics analysis module, enables researchers to identify genes that influence COVID-19 susceptibility, progression and severity.
Congenica Launches New Host Genetics Module to Advance COVID-19 Research
Congenica's new module accelerates research into the relationship between an individual’s genomic variation & COVID-19 susceptibility & clinical outcomes.
Congenica v2.5: Automate Your Workflows
In this release, we made a significant step on our journey to intelligently, safely, and confidently Automate Variant Classification and reporting.
Congenica Express Further Accelerates Identification of Genetic Diseases
Congenica launches an update that will provide automated classification, evidence and reporting of recurrent ‘known’ variants, significantly saving time.